Intervacc AB (publ) (STO:IVACC)
1.100
-0.050 (-4.35%)
Sep 10, 2025, 2:55 PM CET
Intervacc AB Revenue
Intervacc AB had revenue of 7.01M SEK in the quarter ending June 30, 2025, with 156.38% growth. This brings the company's revenue in the last twelve months to 18.24M, up 86.56% year-over-year. In the year 2024, Intervacc AB had annual revenue of 11.79M with 46.84% growth.
Revenue (ttm)
18.24M
Revenue Growth
+86.56%
P/S Ratio
21.48
Revenue / Employee
1.22M
Employees
15
Market Cap
391.94M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11.79M | 3.76M | 46.84% |
Dec 31, 2023 | 8.03M | -4.33M | -35.01% |
Dec 31, 2022 | 12.35M | 3.43M | 38.43% |
Dec 31, 2021 | 8.92M | 1.91M | 27.20% |
Dec 31, 2020 | 7.02M | -7.41M | -51.36% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.37B |
Getinge AB | 35.50B |
Camurus AB | 2.27B |
Medicover AB | 25.22B |
Asker Healthcare Group AB | 15.88B |
BioArctic AB | 1.86B |
AddLife AB | 10.44B |